Kolexia
Cannas Giovanna Hématologie
Cannas Giovanna
Hématologie
Hôpital Edouard Herriot
Lyon, France
122 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Drépanocytose Leucémies Leucémie aigüe myéloïde Anémie Leucémie myéloïde Thalassémie Maladie aigüe Tumeurs hématologiques Bêta-Thalassémie

Collaborateurs

Voir plus
Hot Arnaud
Hot Arnaud
Hôpital Edouard Herriot, Lyon, France
Gauthier Vasserot Alexandra
Gauthier Vasserot Alexandra
Cabinet libéral, Charly, France
Thomas Xavier
Thomas Xavier
Hôpital Lyon Sud, Pierre-Bénite, France
Bertrand Yves
Bertrand Yves
Institut d'hématologie et d’oncologie pédiatrique de Lyon, Lyon, France

Industries

Voir plus
GLOBAL BLOOD THERAPEUTICS FRANCE SAS
4 collaboration(s)
Dernière en 2023
Inter-View Partners France
4 collaboration(s)
Dernière en 2023
Syneos Health, LLC
3 collaboration(s)
Dernière en 2023
Addmedica
2 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
High level of apnea-hypopnea index is associated with an increase in vaso occlusive complications in sickle cell patients
Abstracts from the 17th World Sleep Congress   01 février 2024
Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort-Hydroxyurea (ESCORT-HU) study.
American journal of hematology   22 janvier 2024
Double-Blind Randomized Study to Evaluate the Effect of Hydroxycarbamide on Albuminuria in Adults with Sickle Cell Disease: Sikamic (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
65th ASH Annual Meeting Abstracts   02 novembre 2023
Puberty Onset and Preservation of Fertility in Male Patients with Sickle Cell Disease Treated with Hydroxyurea: Data from the European Sickle Cell Disease Cohort - Hydroxyurea Extension (ESCORT-HU Extension) Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Leg Ulcers in Sickle Cell Disease Patients Undergoing Hydroxyurea Therapy: Insights from Two Large Cohort Studies
65th ASH Annual Meeting Abstracts   02 novembre 2023
Optimizing Albuminuria Assessment in Patients with Sickle Cell Disease: Insights from the Sikamic Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Prevalence of bone complications in young patients with sickle cell disease presenting low bone mineral density.
Bone   17 octobre 2023
Impact of COVID-19 on incidence, clinical presentation, and prognosis of acute chest syndrome in patients with sickle cell disease.
EJHaem   02 octobre 2023
SIKAMIC: Multicentre Randomized Double-blind Placebo-controlled Study to Evaluate the Effect on Albuminuria of 6 Months Treatment With Hydroxycarbamide (Siklos®) or a Placebo in Adults With Sickle Cell Disease:
Essai Clinique (Addmedica)   14 juin 2023
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study: ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension
Essai Clinique (Addmedica)   14 juin 2023